Following a historic sell-off in precious metals, top analysts caution investors that the dramatic price drops in gold and silver may not present a buying opportunity, pointing to ongoing volatility and speculative excess.
A speculative frenzy fueled by geopolitical tensions and dollar fears met its abrupt end last Friday, triggering the worst single-day plunge in silver since 1980 and a massive gold sell-off. Analysts point to leveraged bets and a shifting Fed outlook as key catalysts for the historic crash.
The head of Médecins Sans Frontières warns that Israel's decision to terminate the group's operations in Gaza and the West Bank will deepen the humanitarian crisis, calling it a pretext to restrict vital aid.
CNN legal analyst Elliot Williams predicts lawsuits against the Justice Department and The New York Times by victims whose unredacted nude images were included in the recent Epstein files dump, citing privacy violations.
After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.
Despite a post-earnings slump and near 52-week lows, Abbott Laboratories' resilient medical device unit, strategic expansion in diabetes care, and a landmark acquisition in cancer diagnostics paint a promising long-term picture for this Dividend Aristocrat.
Despite a recent earnings miss, Charles Schwab's stock has significantly outpaced the market over the past year. Wall Street maintains a cautiously optimistic stance, with upgraded ratings and bullish price targets pointing to further potential gains.
Pharmaceutical giant Eli Lilly is investing $3.5 billion to build a new manufacturing facility in rural Pennsylvania, marking its latest move in a massive U.S. expansion aimed at meeting soaring demand for next-generation obesity treatments and capitalizing on reshoring incentives.
Ukrainian President Volodymyr Zelenskiy stated on Monday that achieving a lasting and honorable peace is a realistic goal, as preparations finalize for a new round of negotiations involving Russian and U.S. officials set to begin this week in the UAE capital.
A damning report from the EU's financial watchdog reveals the bloc's struggle to secure the minerals essential for its climate goals, highlighting failed trade deals, stalled recycling, and persistent over-reliance on external suppliers.
With the 2025 tax filing season now open, millions of Americans are looking ahead to their 2026 refunds. We break down how to track your payment, expected wait times, and the potential impact of recent legislation on your bottom line.
Amidst market volatility, Microsoft's diversified empire—spanning cloud, AI, productivity, and gaming—positions it as a resilient long-term holding for investors looking beyond short-term fluctuations.
Wheat markets opened the week under pressure, with futures across Chicago, Kansas City, and Minneapolis exchanges trading lower. A stronger U.S. dollar and mixed fundamental data, including a key Taiwanese purchase, set the tone for a cautious start.
As crypto prediction markets surge past $6B in weekly volume, a new phase of growth beckons. Driven by institutional interest, regulatory evolution, and AI integration, these platforms are poised to redefine speculative finance.
Newly released video evidence shows Islamic State fighters moving unchallenged among aircraft at Niamey's Diori Hamani International Airport, igniting regional tensions and raising urgent questions about security in the Sahel.
Shares of Philip Morris International have significantly outperformed the market over the past year, buoyed by its strategic shift towards reduced-risk products. While analysts remain broadly positive, recent downgrades signal growing caution about the pace of transformation and valuation.
Equinor's stock has gained ground over the past month, yet a detailed fair value analysis suggests the Norwegian energy giant may be trading at a premium. Investors are weighing strong long-term momentum against future headwinds from the green shift.
Lucid Air Grand Touring secures the top spot in a grueling Nordic winter range test, providing a much-needed technical validation for the luxury EV maker amidst a challenging market climate.
Despite a modest price target reduction, Morgan Stanley reaffirms its Overweight rating on Wingstop, citing the chicken wing chain's robust unit expansion and system-wide sales momentum as key drivers for its 2026 outlook.
Garrett Motion (GTX) is drawing strong buy ratings from analysts, with a median price target suggesting over 20% upside, driven by its strategic pivot to zero-emission vehicle technologies and resilient financial profile.
